Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study)

Author： Gerdts Eva   Franklin Stanley   Rieck Åshild   Papademetriou Vasilios   Wachtell Kristian   Nieminen Markku   Dahlof Bjorn   Devereux Richard Blyton  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.18, Iss.4, 2009-08, pp. : 180-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study

By Wachtell Kristian   Gerdts Eva   Aurigemma Gerard P.   Boman Kurt   Dahlöf Björn   Nieminen Markku S.   Olsen Michael Hecht   Okin Peter M.   Palmieri Vittorio   Rokkedal Jens E.   Devereux Richard B.  

Blood Pressure, Vol. 19, Iss. 3, 2010-06 ,pp. : 169-175

Informa Healthcare

Access to resources Recommend Favorite

Left Ventricular Structure and Risk of Cardiovascular Events: A Framingham Heart Study Cardiac Magnetic Resonance Study

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 9, 2015-09 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study

By Kjeldsen Sverre E.   Devereux Richard B.   Hille Darcy A.   Lyle Paulette A.   Dahlöf Björn   Julius Stevo   Edelman Jonathan M.   Snapinn Steven M.   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Lederballe-Pedersen Ole   Lindholm Lars H.   Nieminen Markku S.   Omvik Per   Oparil Suzanne   Wedel Hans    

Blood Pressure, Vol. 18, Iss. 6, 2009-12 ,pp. : 348-361

Informa Healthcare

Access to resources Recommend Favorite

Administration of Angiotensin Receptor II Blockade Improves Vascular Function, Urinary Albumin Excretion, and Left Ventricular Hypertrophy in Low-Risk Essential Hypertensive Patients Receiving Antihypertensive Treatment with Calcium Channel Blockers

By Watanabe Yoshihiko  

Clinical and Experimental Hypertension, Vol. 35, Iss. 2, 2013-04 ,pp. : 87-94

Informa Healthcare

Access to resources Recommend Favorite

Ambulatory pulse pressure predicts cardiovascular events in patients with peripheral arterial disease

By Skoglund Per H.   Östergren Jan   Svensson Per  

Blood Pressure, Vol. 21, Iss. 4, 2012-08 ,pp. : 227-232

Informa Healthcare

Access to resources Recommend Favorite